HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Barbasol TV Ads Planned After 10-Year Hiatus - Perio Exec

This article was originally published in The Rose Sheet

Executive Summary

Barbasol Shave Cream's market share is projected to double within two years due to enhanced marketing efforts, Perio President and CEO Tom Murray predicted.

You may also be interested in...

Barbasol sale

Pfizer's men's shaving business acquired by Dublin, Ohio-based Perio to complement its existing portfolio, which includes Hers shave creams and Nudit depilatory products. With 2000 sales of $18 mil., 11-SKU Barbasol line is widely-distributed, well-recognized brand with "rich heritage" and low price points, Perio says. Divestiture is not indicative of effort to jettison or downsize shaving business, Pfizer maintains. Pharmaceutical firm also markets Schick brand; Pfizer shaving care category accounts for sales of $790 mil., according to the firm

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts